Related Experiment Video
Updated: Feb 2, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
NMT1 inhibition modulates breast cancer progression through stress-triggered JNK pathway
Lu Deng1,2, Xinlei Gao2, Bingjie Liu1,2
1Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences; Shanghai Medical College; Key Laboratory of Breast Cancer in Shanghai; Innovation Center for Cell Signaling Network; Cancer Institutes, Fudan University, 200032, Shanghai, China.
Abstract:
Myristoylation is one of key post-translational modifications that involved in signal transduction, cellular transformation and tumorigenesis. Increasing evidence demonstrates that targeting myristoylation might provide a new strategy for eliminating cancers. However, the underlying mechanisms are still yielded unclear. In this study, we demonstrated that genetic inhibition of N-myristoyltransferase NMT1 suppressed initiation, proliferation and invasion of breast cancer cells either in vitro or in vivo. We identified ROS could negatively regulate NMT1 expression and NMT1 knockdown conversely promoted oxidative stress, which formed a feedback loop. Furthermore, inhibition of NMT1 caused degraded proteins increase and ER stress, which cross-talked with mitochondria to produce more ROS. And both of oxidative stress and ER stress could activate JNK pathway, leading to autophagy which abrogated breast cancer progression especially triple-negative breast cancer (TNBC). These studies provide a preclinical proof of concept for targeting NMT1 as a strategy to treat breast cancer.
Insights
Targeting N-myristoyltransferase 1 (NMT1) inhibits breast cancer progression by inducing oxidative and ER stress, activating pathways that promote autophagy. This offers a new strategy for treating breast cancer, particularly triple-negative breast cancer (TNBC).
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Signaling
Background:
- Myristoylation is a crucial post-translational modification implicated in cancer development.
- Targeting myristoylation presents a potential therapeutic strategy for cancer, but mechanisms remain unclear.
- N-myristoyltransferase 1 (NMT1) plays a role in myristoylation and cancer.
Purpose of the Study:
- To investigate the role of NMT1 in breast cancer progression.
- To elucidate the mechanisms by which NMT1 inhibition affects cancer cells.
- To explore the potential of targeting NMT1 as a breast cancer therapy.
Main Methods:
- Genetic inhibition of NMT1 in breast cancer cells (in vitro and in vivo).
- Analysis of reactive oxygen species (ROS) and endoplasmic reticulum (ER) stress.
- Investigation of protein degradation, mitochondrial function, and JNK/autophagy pathways.
Main Results:
- NMT1 inhibition suppressed breast cancer initiation, proliferation, and invasion.
- A feedback loop between NMT1, ROS, and oxidative stress was identified.
- NMT1 inhibition induced protein degradation, ER stress, and ROS production, activating JNK and autophagy, which inhibited cancer progression, especially in triple-negative breast cancer (TNBC).
Conclusions:
- NMT1 is a critical regulator of breast cancer cell behavior.
- Targeting NMT1 induces a cascade of cellular stresses (oxidative, ER) leading to autophagy.
- NMT1 inhibition represents a promising preclinical strategy for breast cancer treatment, particularly TNBC.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Feedback Inhibition
Responses to Salt Stress
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Enzyme Inhibition

